Author: Checconi, Paola; De Angelis, Marta; Marcocci, Maria Elena; Fraternale, Alessandra; Magnani, Mauro; Palamara, Anna Teresa; Nencioni, Lucia
Title: Redox-Modulating Agents in the Treatment of Viral Infections Cord-id: 6kibrlkx Document date: 2020_6_8
ID: 6kibrlkx
Snippet: Viruses use cell machinery to replicate their genome and produce viral proteins. For this reason, several intracellular factors, including the redox state, might directly or indirectly affect the progression and outcome of viral infection. In physiological conditions, the redox balance between oxidant and antioxidant species is maintained by enzymatic and non-enzymatic systems, and it finely regulates several cell functions. Different viruses break this equilibrium and induce an oxidative stress
Document: Viruses use cell machinery to replicate their genome and produce viral proteins. For this reason, several intracellular factors, including the redox state, might directly or indirectly affect the progression and outcome of viral infection. In physiological conditions, the redox balance between oxidant and antioxidant species is maintained by enzymatic and non-enzymatic systems, and it finely regulates several cell functions. Different viruses break this equilibrium and induce an oxidative stress that in turn facilitates specific steps of the virus lifecycle and activates an inflammatory response. In this context, many studies highlighted the importance of redox-sensitive pathways as novel cell-based targets for therapies aimed at blocking both viral replication and virus-induced inflammation. In the review, we discuss the most recent findings in this field. In particular, we describe the effects of natural or synthetic redox-modulating molecules in inhibiting DNA or RNA virus replication as well as inflammatory pathways. The importance of the antioxidant transcription factor Nrf2 is also discussed. Most of the data reported here are on influenza virus infection. We believe that this approach could be usefully applied to fight other acute respiratory viral infections characterized by a strong inflammatory response, like COVID-19.
Search related documents:
Co phrase search for related documents- action mechanism and acute respiratory syndrome sars cov coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- action mechanism and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- action mechanism and adaptive innate immunity: 1, 2, 3, 4, 5
- action mechanism and adaptor protein: 1
- action mechanism and additional mechanism: 1, 2, 3, 4, 5, 6
- action mechanism and additive synergistic: 1, 2
- activator signal transducer and acute respiratory syndrome sars cov coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- activator signal transducer and adaptive innate: 1, 2, 3, 4
- activator signal transducer and adaptive innate immunity: 1
- active site and acute respiratory syndrome sars cov coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active site and adaptive innate: 1, 2
- active site and additional mechanism: 1
- acute phase and adaptive humoral: 1, 2
- acute phase and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute phase and adaptive innate immunity: 1, 2, 3
- acute phase and adaptive innate immunity function: 1
- acute phase and additive synergistic: 1
- acute phase and additive synergistic effect: 1
- acute respiratory syndrome sars cov coronavirus and additive synergistic effect compound: 1
Co phrase search for related documents, hyperlinks ordered by date